Time to Colonoscopy after Positive Fecal Blood Test in Four US Health Care Systems

被引:105
作者
Chubak, Jessica [1 ]
Garcia, Michael P. [2 ]
Burnett-Hartman, Andrea N. [2 ,3 ]
Zheng, Yingye [2 ]
Corley, Douglas A. [4 ]
Halm, Ethan A. [5 ]
Singal, Amit G. [5 ]
Klabunde, Carrie N. [6 ]
Doubeni, Chyke A. [7 ]
Kamineni, Aruna [1 ]
Levin, Theodore R. [8 ]
Schottinger, Joanne E. [9 ]
Green, Beverly B. [1 ]
Quinn, Virginia P. [9 ]
Rutter, Carolyn M. [10 ]
机构
[1] Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[3] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA
[4] Kaiser Permanente No Calif, Oakland, CA USA
[5] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Clin Sci, Dallas, TX 75390 USA
[6] NIH, Off Director, Rockville, MD USA
[7] Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, Philadelphia, PA 19104 USA
[8] Kaiser Permanente Med Ctr, Walnut Creek, CA USA
[9] Kaiser Permanente So Calif, Pasadena, CA 91101 USA
[10] RAND Corp, Santa Monica, CA USA
关键词
CANCER SCREENING-PROGRAM; OCCULT BLOOD; FOLLOW-UP; COLORECTAL-CANCER; DIAGNOSTIC EVALUATION; RANDOMIZED-TRIAL; COLON EVALUATION; TASK-FORCE; PATIENT; IMPROVEMENT;
D O I
10.1158/1055-9965.EPI-15-0470
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: To reduce colorectal cancer mortality, positive fecal blood tests must be followed by colonoscopy. Methods: We identified 62,384 individuals ages 50 to 89 years with a positive fecal blood test between January 1, 2011 and December 31, 2012 in four health care systems within the Population-Based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium. We estimated the probability of follow-up colonoscopy and 95% confidence intervals (CI) using the Kaplan-Meier method. Overall differences in cumulative incidence of follow-up across health care systems were assessed with the log-rank test. HRs and 95% CIs were estimated from multivariate Cox proportional hazards models. Results: Most patients who received a colonoscopy did so within 6 months of their positive fecal blood test, although follow-up rates varied across health care systems (P < 0.001). Median days to colonoscopy ranged from 41 (95% CI, 40-41) to 174 95% CI, 123-343); percent followed-up by 12 months ranged from 58.1% 95% CI, 51.6%-63.7%) to 83.8% 95% CI, 83.4%-84.3%) and differences across health care systems were also observed at 1, 2, 3, and 6 months. Increasing age and comorbidity score were associated with lower follow-up rates. Conclusion: Individual characteristics and health care system were associated with colonoscopy after positive fecal blood tests. Patterns were consistent across health care systems, but proportions of patients receiving follow-up varied. These findings suggest that there is room to improve follow-up of positive colorectal cancer screening tests. Impact: Understanding the timing of colonoscopy after positive fecal blood tests and characteristics associated with lack of follow-up may inform future efforts to improve follow-up. (C) 2016 AACR.
引用
收藏
页码:344 / 350
页数:7
相关论文
共 35 条
[1]
[Anonymous], STAT COUNT QUICKF
[2]
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement [J].
Calonge, Ned ;
Petitti, Diana B. ;
DeWitt, Thomas G. ;
Dietrich, Allen J. ;
Gregory, Kimberly D. ;
Harris, Russell ;
Isham, George ;
LeFevre, Michael L. ;
Leipzig, Roseanne M. ;
Loveland-Cherry, Carol ;
Marion, Lucy N. ;
Melnyk, Bernadette ;
Moyer, Virginia A. ;
Ockene, Judith K. ;
Sawaya, George F. ;
Yawn, Barbara P. .
ANNALS OF INTERNAL MEDICINE, 2008, 149 (09) :627-+
[3]
Lack of Follow-up After Fecal Occult Blood Testing in Older Adults [J].
Carlson, Charlotte M. ;
Kirby, Katharine A. ;
Casadei, Michele A. ;
Partin, Melissa R. ;
Kistler, Christine E. ;
Walter, Louise C. .
ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (03) :249-256
[4]
A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[5]
Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008 [J].
Choi, Kui Son ;
Lee, Hoo-Yeon ;
Jun, Jae Kwan ;
Shin, Aesun ;
Park, Eun-Cheol .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (06) :1070-1077
[6]
A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening [J].
Church, TR ;
Yeazel, MW ;
Jones, RM ;
Kochevar, LK ;
Watt, GD ;
Mongin, SJ ;
Cordes, JE ;
Engelhard, D .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (10) :770-780
[7]
Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test [J].
Ferrat, E. ;
Le Breton, J. ;
Veerabudun, K. ;
Bercier, S. ;
Brixi, Z. ;
Khoshnood, B. ;
Paillaud, E. ;
Attali, C. ;
Bastuji-Garin, S. .
BRITISH JOURNAL OF CANCER, 2013, 109 (06) :1437-1444
[8]
Barriers to full colon evaluation for a positive fecal occult blood test [J].
Fisher, Deborah A. ;
Jeffreys, Amy ;
Coffman, Cynthia J. ;
Fasanella, Kenneth .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (06) :1232-1235
[9]
Colorectal cancer screening, comorbidity, and follow-up in elderly patients [J].
Garman, Katherine S. ;
Jeffreys, Amy ;
Coffman, Cynthia ;
Fisher, Deborah A. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2006, 332 (04) :159-163
[10]
Time from Positive Screening Fecal Occult Blood Test to Colonoscopy and Risk of Neoplasia [J].
Gellad, Ziad F. ;
Almirall, Daniel ;
Provenzale, Dawn ;
Fisher, Deborah A. .
DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (11) :2497-2502